A

argenx

Develops antibody-based therapies for autoimmune diseases

Associate Director Market Access

Business OperationsConfirmed live in the last 24 hours
Full-timeRemote in Germany

About the Job

Requirements

  • A minimum of 10 years of relevant industry experience in biotech or pharma is required.
  • At least 6 years of German field-based Market Access experience is required, ideally complemented by statutory health insurance and/or KV experience.
  • Advanced graduate-level training in natural sciences, medicine, business, engineering, or finance is required.
  • Fluency in German and English is required.
  • A deep understanding of the German healthcare system is required, especially statutory health insurance structure, hospital financing (including DRG and NUB), and outpatient and inpatient access pathways.
  • Familiarity with AMNOG processes and how national decisions are implemented regionally is required.
  • A successful track record in negotiating rebate contracts is required.
  • Stakeholder management capabilities and an external network including KV, statutory health insurance, and pharmacies are required.
  • Strategic thinking and negotiation skills are required.
  • The role requires the ability to work autonomously in a field-based setting and collaboratively within cross-functional teams and networks.
  • Demonstrated experience with project management, proactive planning, priority setting, and securing alignment is required.
  • Regular travel is required.

Responsibilities

  • Develop and implement German regional market access strategies to secure and optimize reimbursement, pricing, and access conditions for the product portfolio.
  • Serve as the key interface between the company and regional stakeholders, including statutory health insurance funds, health authorities, hospital stakeholders, key opinion leaders, and other decision-makers.
  • Align local implementation with national access strategies, build partnerships with key stakeholders, and help secure sustainable reimbursement and funding pathways in the region.
  • Establish and maintain relationships with regional payers, statutory health insurance entities, KV associations, hospital purchasing groups, medical societies, and other access influencers.
  • Act as the field-based point of contact for regional reimbursement and pricing discussions.
  • Lead contracting negotiations and implementation of managed entry agreements where relevant.
  • Identify and act on regional access opportunities, policy shifts, or barriers to adoption.
  • Coordinate with national Market Access, Medical Affairs, and Commercial teams.
  • Collaborate with Commercial and Medical Field Force teams to support product uptake and overcome access hurdles.
  • Provide field insights to national Market Access and brand teams to refine strategy.
  • Represent regional access considerations in brand planning and launch readiness discussions.
  • Monitor and support tender submissions and negotiations where applicable, especially in hospital markets.
  • Liaise with hospital pharmacies, purchasing departments, and DRG/NUB reimbursement offices.
  • Deliver internal training on regional access processes, payer expectations, and relevant healthcare policy updates.
  • Serve as an internal expert on the German regional healthcare and reimbursement landscape.

Desired Qualifications

  • Experience complemented by statutory health insurance and/or KV experience is ideal.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs